Moderate
Suspected
描述
Carbamazepine may reduce levodopa efficacy through enzyme induction and pharmacodynamic antagonism, potentially worsening Parkinson's disease control.
机制
Carbamazepine induces hepatic enzymes that metabolize levodopa's carbidopa component, potentially increasing peripheral levodopa breakdown; it may also block dopaminergic effects centrally.
临床意义
Worsening motor function has been reported in Parkinson's patients starting carbamazepine; tremor and rigidity may increase.
处理措施
Monitor motor function closely; levodopa dose increase may be needed; consider alternative anticonvulsants (lamotrigine, gabapentin).